These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 21165656)
1. CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid. Yoshida T; Sekine T; Aisaki K; Mikami T; Kanno J; Okayasu I J Gastroenterol; 2011 Mar; 46(3):339-49. PubMed ID: 21165656 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 inhibits cell division and increases apoptosis in gastric cancer. Tang Z; He G; Xu J; Zhongfu L J Surg Res; 2017 May; 211():1-7. PubMed ID: 28501104 [TBL] [Abstract][Full Text] [Related]
3. CITED2 affects leukemic cell survival by interfering with p53 activation. Mattes K; Berger G; Geugien M; Vellenga E; Schepers H Cell Death Dis; 2017 Oct; 8(10):e3132. PubMed ID: 29072699 [TBL] [Abstract][Full Text] [Related]
4. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Ohkusa T; Okayasu I; Ogihara T; Morita K; Ogawa M; Sato N Gut; 2003 Jan; 52(1):79-83. PubMed ID: 12477765 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis. Wu ZZ; Sun NK; Chao CC J Cell Physiol; 2011 Sep; 226(9):2415-28. PubMed ID: 21660965 [TBL] [Abstract][Full Text] [Related]
6. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis. Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288 [TBL] [Abstract][Full Text] [Related]
7. Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2. Regel I; Merkl L; Friedrich T; Burgermeister E; Zimmermann W; Einwächter H; Herrmann K; Langer R; Röcken C; Hofheinz R; Schmid R; Ebert MP Gastroenterology; 2012 Jul; 143(1):99-109.e10. PubMed ID: 22465428 [TBL] [Abstract][Full Text] [Related]
8. A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion. Bai L; Merchant JL FEBS Lett; 2007 Dec; 581(30):5904-10. PubMed ID: 18054336 [TBL] [Abstract][Full Text] [Related]
9. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene. Liu YC; Chang PY; Chao CC Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430 [TBL] [Abstract][Full Text] [Related]
10. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α. Yoon H; Lim JH; Cho CH; Huang LE; Park JW Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214 [TBL] [Abstract][Full Text] [Related]
11. High Glucose-Repressed CITED2 Expression Through miR-200b Triggers the Unfolded Protein Response and Endoplasmic Reticulum Stress. Gu H; Yu J; Dong D; Zhou Q; Wang JY; Fang S; Yang P Diabetes; 2016 Jan; 65(1):149-63. PubMed ID: 26450995 [TBL] [Abstract][Full Text] [Related]
12. Altered endoplasmic reticulum stress affects translation in inactive colon tissue from patients with ulcerative colitis. Tréton X; Pédruzzi E; Cazals-Hatem D; Grodet A; Panis Y; Groyer A; Moreau R; Bouhnik Y; Daniel F; Ogier-Denis E Gastroenterology; 2011 Sep; 141(3):1024-35. PubMed ID: 21699776 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer. Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016 [TBL] [Abstract][Full Text] [Related]
14. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia. Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations. Planell N; Lozano JJ; Mora-Buch R; Masamunt MC; Jimeno M; Ordás I; Esteller M; Ricart E; Piqué JM; Panés J; Salas A Gut; 2013 Jul; 62(7):967-76. PubMed ID: 23135761 [TBL] [Abstract][Full Text] [Related]
16. CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance. Minemura H; Takagi K; Sato A; Takahashi H; Miki Y; Shibahara Y; Watanabe M; Ishida T; Sasano H; Suzuki T Cancer Sci; 2016 Dec; 107(12):1898-1908. PubMed ID: 27627783 [TBL] [Abstract][Full Text] [Related]
17. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis. Arai N; Mitomi H; Ohtani Y; Igarashi M; Kakita A; Okayasu I Mod Pathol; 1999 Jun; 12(6):604-11. PubMed ID: 10392637 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia. Fujii S; Fujimori T; Chiba T J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330 [TBL] [Abstract][Full Text] [Related]